Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteraemia: A Retrospective Cohort Study

Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteraemia: A Retrospective Cohort Study

Background: First-line treatments for methicillin-susceptible <i>S. aureus</i> (MSSA) bacteraemia are nafcillin, oxacillin, or cefazolin. Regional shortages of these antibiotics force clinicians to use other options like dicloxacillin and cephalotin. This study aims to describe and compa...

Full description

Bibliographic Details
Main Authors: Alejandro Quiñonez-Flores, Bernardo A. Martinez-Guerra, Carla M. Román-Montes, Karla M. Tamez-Torres, María F. González-Lara, Alfredo Ponce-de-León, Sandra Rajme-López
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Antibiotics
Subjects:
cephalotin
cephalothin
dicloxacillin
Staphylococcus aureus
MSSA
bloodstream infection
Online Access:https://www.mdpi.com/2079-6382/13/2/176

Similar Items

Similar Items